Recent MSK Discoveries & Advances

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
377 News Items found
In the Lab
abstract red and blue lines suggestive of metabolic pathways
Scientists Create First-of-Its-Kind Metabolic Road Map of Cancer
The online resource will serve as a benchmark for researchers studying metabolism and cancer.
In the Clinic
Physician-scientist Ross Levine and research technician Aishwarya Krishnan speak in the lab
MSK Opens New Clinic to Monitor People with a Genetic Risk for Developing Blood Cancer
MSK's new clinic will focus on clonal hematopoiesis, a condition related to aging that increases the risk of developing certain blood cancers.
In the Lab
A gray blob marked RAS linked to colorful rods marked ICMT
Deciphering How Membrane Enzymes Work, with a Little Help from Beetles
The atomic structure of an elusive type of membrane protein has finally been solved by scientists at the Sloan Kettering Institute.
In the Lab
Illustration of cells with blue nuclei that have green DNA bits floating in the cytoplasm
Escape Artists: Cancer Cells Mimic Immune Cell Activity to Spread
Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.
In the Lab
Three-dimensional reconstruction of the blood vessels in a mouse thymus using light-sheet fluorescent microscopy
New Hope for Repairing a Damaged or Aging Immune System
Scientists have uncovered a molecule that, in mice, can promote the regeneration of the thymus, where T cells develop.
Q&A
MP1104 binding to the kappa opioid receptor
Building a Safer Opioid: MSK Research Seeks to Develop New Ways to Relieve Pain
Science could lead to a new type of opioid drug that blocks pain but has a lower potential for addiction or abuse.
In the Lab
cryo-EM picture of mTORC1
Scientists Unlock Structure of mTOR, a Key Cancer Cell Signaling Protein
Structural biologists in the Sloan Kettering Institute have used a powerful tool called cryo-EM to solve the structure of a major cancer player.
In the News
Gears with 2016 and 2017
Year in Review: The Science and Technology that Shaped Cancer Care in 2017
As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year.
In the Lab
Sloan Kettering Institute Director Joan Massagué with laboratory member Karuna Ganesh
When Cancer Spreads: Research Focuses on Better Ways to Treat Metastasis
MSK investigators are learning how cancer cells escape from the original tumor and hide out in the body. Their goal is to prevent metastatic tumors from forming.
In the Lab
A microscopic view of genetically engineered mouse tumor and a human FL-HCC tumor
With Help of CRISPR, Scientists Unravel the Cause of a Rare Liver Cancer
A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.